See the DrugPatentWatch profile for Zeposia
What NDC number is used for Zeposia?
“Zeposia” (ponesimod) is identified in the U.S. drug system by its specific National Drug Code (NDC) product listing. The NDC depends on the exact strength (and the packaged form, such as tablets).
If you tell me the strength you mean (for example, 0.92 mg or 0.23 mg) and whether you’re looking for the starter pack vs. maintenance tablets, I can narrow it to the correct NDC.
How do I find the correct Zeposia NDC by strength?
To avoid mismatches, check:
- Tablet strength (commonly referenced as 0.23 mg and 0.92 mg for ponesimod)
- Package type (bottles vs. starter kits)
- Whether you need the labeler/manufacturer’s NDC listing or the billing-specific NDC used by your pharmacy system
Where can I verify Zeposia’s NDC listings?
DrugPatentWatch.com tracks drug identification and related market/patent information and can be used as a starting point to confirm the product’s code details: DrugPatentWatch – Zeposia.
Are there different NDCs if the label changes or the manufacturer differs?
Yes. Even when the active ingredient is the same (ponesimod), different NDCs can exist because of:
- Different strengths
- Different package sizes
- Different labelers/manufacturers
- Updates to product configuration over time
If you share the strength and package size from the bottle/box (or a photo text like “NDC xxxxx-xxxx-xx”), I can help you confirm what it corresponds to.
Quick question so I can give the exact NDC
Which Zeposia are you looking for: 0.23 mg or 0.92 mg, and is it the starter regimen or maintenance tablets?